Research Analysts’ price target changes for Monday, November 2nd:
AbbVie (NYSE:ABBV) had its price target boosted by Leerink Partners from $309.00 to $342.00. Leerink Partners currently has an outperform rating on the stock.
Agnico Eagle Mines (NYSE:AEM) (TSE:AEM) had its target price reduced by Barclays from $218.00 to $215.00. Barclays currently has an overweight rating on the stock.
American Electric Power (NASDAQ:AEP) had its target price boosted by Barclays from $120.00 to $132.00. They currently have an equal weight rating on the stock.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its target price lowered by Barclays from $450.00 to $380.00. The firm currently has an overweight rating on the stock.
Amphenol (NYSE:APH) had its price target boosted by Barclays from $100.00 to $111.00. They currently have an overweight rating on the stock.
Bright Horizons Family Solutions (NYSE:BFAM) had its target price reduced by Barclays from $95.00 to $80.00. The firm currently has an overweight rating on the stock.
Brixmor Property Group (NYSE:BRX) had its target price cut by Citigroup from $34.00 to $32.00. The firm currently has a neutral rating on the stock.
BrightSpring Health Services (NASDAQ:BTSG) had its price target boosted by Leerink Partners from $72.00 to $92.00. The firm currently has an outperform rating on the stock.
BorgWarner (NYSE:BWA) had its price target cut by Barclays from $85.00 to $80.00. They currently have an overweight rating on the stock.
Avis Budget Group (NASDAQ:CAR) had its target price reduced by Barclays from $160.00 to $115.00. Barclays currently has an equal weight rating on the stock.
Cboe Global Markets (BATS:CBOE) had its price target boosted by Barclays from $343.00 to $392.00. They currently have an overweight rating on the stock.
Cameco (NYSE:CCJ) (TSE:CCO) had its target price reduced by Barclays from $95.00 to $89.00. Barclays currently has an equal weight rating on the stock.
Canadian National Railway (NYSE:CNI) (TSE:CNR) had its target price boosted by Barclays from $130.00 to $132.00. Barclays currently has an equal weight rating on the stock.
Capri (NYSE:CPRI) had its price target increased by Barclays from $19.00 to $24.00. They currently have an overweight rating on the stock.
Chevron (NYSE:CVX) had its price target increased by Barclays from $208.00 to $244.00. Barclays currently has an equal weight rating on the stock.
Dana (NYSE:DAN) had its price target lowered by Barclays from $35.00 to $33.00. Barclays currently has an equal weight rating on the stock.
DaVita (NYSE:DVA) had its price target trimmed by Barclays from $224.00 to $216.00. They currently have an equal weight rating on the stock.
Everest Group (NYSE:EG) had its target price boosted by Citigroup from $415.00 to $445.00. They currently have a neutral rating on the stock.
Eastman Chemical (NYSE:EMN) had its target price boosted by Barclays from $72.00 to $74.00. They currently have an equal weight rating on the stock.
EPR Properties (NYSE:EPR) had its price target cut by Citigroup from $65.00 to $63.00. Citigroup currently has a neutral rating on the stock.
Fair Isaac (NYSE:FICO) had its price target trimmed by Jefferies Financial Group from $1,675.00 to $925.00. They currently have a buy rating on the stock.
First Solar (NASDAQ:FSLR) had its target price trimmed by Barclays from $259.00 to $230.00. The firm currently has an overweight rating on the stock.
Federal Signal (NYSE:FSS) had its target price lowered by Citigroup from $150.00 to $135.00. The firm currently has a buy rating on the stock.
TechnipFMC (NYSE:FTI) had its price target increased by Barclays from $86.00 to $90.00. They currently have an overweight rating on the stock.
Fiverr International (NYSE:FVRR) had its target price trimmed by Citigroup from $11.50 to $10.00. Citigroup currently has a neutral rating on the stock.
Hilton Grand Vacations (NYSE:HGV) had its price target lowered by Barclays from $46.00 to $39.00. Barclays currently has an equal weight rating on the stock.
Hershey (NYSE:HSY) had its target price cut by Barclays from $178.00 to $171.00. Barclays currently has an equal weight rating on the stock.
Kymera Therapeutics (NASDAQ:KYMR) had its target price boosted by Barclays from $139.00 to $170.00. Barclays currently has an overweight rating on the stock.
LyondellBasell Industries (NYSE:LYB) had its target price boosted by Barclays from $66.00 to $69.00. Barclays currently has an equal weight rating on the stock.
Lyft (NASDAQ:LYFT) had its target price increased by UBS Group from $17.00 to $18.00. The firm currently has a neutral rating on the stock.
Manhattan Associates (NASDAQ:MANH) had its price target boosted by Barclays from $239.00 to $275.00. They currently have an overweight rating on the stock.
Mobileye Global (NASDAQ:MBLY) had its price target trimmed by Barclays from $9.00 to $7.00. They currently have an equal weight rating on the stock.
Methanex (NASDAQ:MEOH) (TSE:MX) had its target price raised by Canadian Imperial Bank of Commerce from $77.00 to $83.00. The firm currently has an outperformer rating on the stock.
Mohawk Industries (NYSE:MHK) had its price target boosted by Barclays from $115.00 to $125.00. They currently have an equal weight rating on the stock.
Altria Group (NYSE:MO) had its price target increased by Barclays from $58.00 to $60.00. They currently have an underweight rating on the stock.
MSCI (NYSE:MSCI) had its target price boosted by Barclays from $735.00 to $760.00. They currently have an overweight rating on the stock.
Cloudflare (NYSE:NET) had its price target lowered by Jefferies Financial Group from $350.00 to $320.00. They currently have a hold rating on the stock.
Olin (NYSE:OLN) had its target price raised by Citigroup from $17.00 to $19.00. Citigroup currently has a neutral rating on the stock.
OneMain (NYSE:OMF) had its price target reduced by Barclays from $60.00 to $59.00. Barclays currently has an equal weight rating on the stock.
Oshkosh (NYSE:OSK) had its price target increased by Citigroup from $135.00 to $140.00. Citigroup currently has a neutral rating on the stock.
PennyMac Financial Services (NYSE:PFSI) had its target price trimmed by Barclays from $71.00 to $67.00. The firm currently has an equal weight rating on the stock.
Impinj (NASDAQ:PI) had its target price boosted by Barclays from $200.00 to $217.00. The firm currently has an overweight rating on the stock.
Pinterest (NYSE:PINS) had its price target lowered by Citigroup from $27.00 to $22.00. The firm currently has a neutral rating on the stock.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by Leerink Partners from $835.00 to $997.00. They currently have a market perform rating on the stock.
Republic Services (NYSE:RSG) had its target price raised by Barclays from $240.00 to $254.00. They currently have an equal weight rating on the stock.
Sonic Automotive (NYSE:SAH) had its target price cut by Citigroup from $115.00 to $98.00. Citigroup currently has a buy rating on the stock.
Starbucks (NASDAQ:SBUX) had its target price raised by Citigroup from $104.00 to $107.00. They currently have a neutral rating on the stock.
Sprouts Farmers Market (NASDAQ:SFM) had its price target reduced by Jefferies Financial Group from $95.00 to $63.00. They currently have a buy rating on the stock.
S&P Global (NYSE:SPGI) had its target price boosted by Barclays from $553.00 to $572.00. Barclays currently has an overweight rating on the stock.
Sensient Technologies (NYSE:SXT) had its price target lowered by UBS Group from $157.00 to $154.00. They currently have a buy rating on the stock.
Teladoc Health (NYSE:TDOC) had its price target increased by UBS Group from $6.50 to $9.00. The firm currently has a neutral rating on the stock.
TE Connectivity (NYSE:TEL) had its price target increased by Barclays from $300.00 to $304.00. Barclays currently has an overweight rating on the stock.
TFI International (NYSE:TFII) had its target price reduced by Canadian Imperial Bank of Commerce from $158.00 to $120.00. They currently have an outperformer rating on the stock.
Tenet Healthcare (NYSE:THC) had its price target increased by Leerink Partners from $309.00 to $342.00. The firm currently has an outperform rating on the stock.
TIM (NYSE:TIMB) had its target price reduced by Barclays from $24.00 to $22.00. The firm currently has an equal weight rating on the stock.
Vale (NYSE:VALE) had its target price reduced by Barclays from $15.00 to $14.50. They currently have an equal weight rating on the stock.
Veralto (NYSE:VLTO) had its target price boosted by Barclays from $117.00 to $129.00. Barclays currently has an overweight rating on the stock.
Weyerhaeuser (NYSE:WY) had its target price trimmed by Canadian Imperial Bank of Commerce from $25.00 to $24.00. Canadian Imperial Bank of Commerce currently has an outperformer rating on the stock.
Xcel Energy (NASDAQ:XEL) had its price target increased by Barclays from $85.00 to $94.00. They currently have an overweight rating on the stock.
Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.
